Self-Efficacy of Saudi Patients with Autoimmune Diseases in Managing Hydroxychloroquine-Induced Ocular Complications: A Cross-Sectional Survey

Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are common autoimmune diseases (AD) that affect joints and have multi-organ involvement that results in disability, morbidity, and increased mortality. Both conditions are known to cause a wide range of ocular manifestations. Antimalar...

Descripción completa

Detalles Bibliográficos
Autores principales: Aldarwesh, Amal, Almustanyir, Ali, Alhayan, Duja, Alharthi, Mazoon, Alblowi, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951227/
https://www.ncbi.nlm.nih.gov/pubmed/35327043
http://dx.doi.org/10.3390/healthcare10030565
_version_ 1784675333081923584
author Aldarwesh, Amal
Almustanyir, Ali
Alhayan, Duja
Alharthi, Mazoon
Alblowi, Mohammed
author_facet Aldarwesh, Amal
Almustanyir, Ali
Alhayan, Duja
Alharthi, Mazoon
Alblowi, Mohammed
author_sort Aldarwesh, Amal
collection PubMed
description Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are common autoimmune diseases (AD) that affect joints and have multi-organ involvement that results in disability, morbidity, and increased mortality. Both conditions are known to cause a wide range of ocular manifestations. Antimalarial drugs, mainly hydroxychloroquine (HCQ), are among the treatment options for AD that is uniquely characterized by retinopathy as a main side effect. This study examines self-efficacy levels in autoimmune disease patients who were or are currently treated with HCQ and related factors such as patient education, communication with the physician, self-education, and ability to cope with the disease.
format Online
Article
Text
id pubmed-8951227
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89512272022-03-26 Self-Efficacy of Saudi Patients with Autoimmune Diseases in Managing Hydroxychloroquine-Induced Ocular Complications: A Cross-Sectional Survey Aldarwesh, Amal Almustanyir, Ali Alhayan, Duja Alharthi, Mazoon Alblowi, Mohammed Healthcare (Basel) Article Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are common autoimmune diseases (AD) that affect joints and have multi-organ involvement that results in disability, morbidity, and increased mortality. Both conditions are known to cause a wide range of ocular manifestations. Antimalarial drugs, mainly hydroxychloroquine (HCQ), are among the treatment options for AD that is uniquely characterized by retinopathy as a main side effect. This study examines self-efficacy levels in autoimmune disease patients who were or are currently treated with HCQ and related factors such as patient education, communication with the physician, self-education, and ability to cope with the disease. MDPI 2022-03-17 /pmc/articles/PMC8951227/ /pubmed/35327043 http://dx.doi.org/10.3390/healthcare10030565 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Aldarwesh, Amal
Almustanyir, Ali
Alhayan, Duja
Alharthi, Mazoon
Alblowi, Mohammed
Self-Efficacy of Saudi Patients with Autoimmune Diseases in Managing Hydroxychloroquine-Induced Ocular Complications: A Cross-Sectional Survey
title Self-Efficacy of Saudi Patients with Autoimmune Diseases in Managing Hydroxychloroquine-Induced Ocular Complications: A Cross-Sectional Survey
title_full Self-Efficacy of Saudi Patients with Autoimmune Diseases in Managing Hydroxychloroquine-Induced Ocular Complications: A Cross-Sectional Survey
title_fullStr Self-Efficacy of Saudi Patients with Autoimmune Diseases in Managing Hydroxychloroquine-Induced Ocular Complications: A Cross-Sectional Survey
title_full_unstemmed Self-Efficacy of Saudi Patients with Autoimmune Diseases in Managing Hydroxychloroquine-Induced Ocular Complications: A Cross-Sectional Survey
title_short Self-Efficacy of Saudi Patients with Autoimmune Diseases in Managing Hydroxychloroquine-Induced Ocular Complications: A Cross-Sectional Survey
title_sort self-efficacy of saudi patients with autoimmune diseases in managing hydroxychloroquine-induced ocular complications: a cross-sectional survey
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951227/
https://www.ncbi.nlm.nih.gov/pubmed/35327043
http://dx.doi.org/10.3390/healthcare10030565
work_keys_str_mv AT aldarweshamal selfefficacyofsaudipatientswithautoimmunediseasesinmanaginghydroxychloroquineinducedocularcomplicationsacrosssectionalsurvey
AT almustanyirali selfefficacyofsaudipatientswithautoimmunediseasesinmanaginghydroxychloroquineinducedocularcomplicationsacrosssectionalsurvey
AT alhayanduja selfefficacyofsaudipatientswithautoimmunediseasesinmanaginghydroxychloroquineinducedocularcomplicationsacrosssectionalsurvey
AT alharthimazoon selfefficacyofsaudipatientswithautoimmunediseasesinmanaginghydroxychloroquineinducedocularcomplicationsacrosssectionalsurvey
AT alblowimohammed selfefficacyofsaudipatientswithautoimmunediseasesinmanaginghydroxychloroquineinducedocularcomplicationsacrosssectionalsurvey

Ejemplares similares